1-3 of 3
Howard J. Latimer, IV, BS
Close
Sort by
Journal Articles

Manufacturing an Enhanced CAR T Cell Product By Inhibition of the PI3K/Akt Pathway During T Cell Expansion Results in Improved In Vivo Efficacy of Anti-BCMA CAR T Cells

Molly R. Perkins, D.Phil., Shannon Grande, PhD, Amanda Hamel, BS, Holly M. Horton, PhD, Tracy E. Garrett, BA, Sara M. Miller, Howard J. Latimer, IV, BS, Christopher J. Horvath, DVM, MS, DACVP, Michael Kuczewski, MS, Kevin M. Friedman, PhD, Richard A. Morgan, PhD
Journal: Blood
Blood (2015) 126 (23): 1893.
https://doi.org/10.1182/blood.V126.23.1893.1893
Published: 2015
Journal Articles

Characterization of Lentiviral Vector Derived Anti-Bcma CAR T Cells Reveals Key Parameters for Robust Manufacturing of Cell-Based Gene Therapies for Multiple Myeloma

Graham Lilley, M.S., Alden Ladd, Daniel Cossette, Laura Viggiano, Gregory Hopkins, John W. Evans, PhD, Mingli Li, M.S., Howard J. Latimer, IV, BS, Sara M. Miller, Michael Kuczewski, MS, Wendy Bakeman, Kayla MacLeod, Kevin M. Friedman, PhD, Dawn A Maier, M.S., Michael Paglia, M.S., Richard A. Morgan, PhD, Mark D Angelino, PhD
Journal: Blood
Blood (2015) 126 (23): 3243.
https://doi.org/10.1182/blood.V126.23.3243.3243
Published: 2015
Journal Articles

A Novel and Highly Potent CAR T Cell Drug Product for Treatment of BCMA-Expressing Hematological Malignances

Alena A. Chekmasova, PhD, Holly M. Horton, PhD, Tracy E. Garrett, BA, John W. Evans, PhD, Johanna Griecci, BS, Amanda Hamel, BS, Howard J. Latimer, IV, BS, Stacie L. Seidel, MA, Byoung Y. Ryu, PhD, Michael Kuczewski, MS, Christopher J. Horvath, DVM, MS, DACVP, Kevin M. Friedman, PhD, Richard A. Morgan, PhD
Journal: Blood
Blood (2015) 126 (23): 3094.
https://doi.org/10.1182/blood.V126.23.3094.3094
Published: 2015